Effects of ipragliflozin on left ventricular diastolic function in patients with type 2 diabetes and heart failure with preserved ejection fraction: The EXCEED randomized controlled multicenter study

AIM: We carried out a randomized controlled trial using ipragliflozin. We analyzed changes in diastolic function using echocardiography in patients with type 2 diabetes and heart failure with preserved ejection fraction. METHODS: We carried out an open‐label, multicenter, randomized, two‐arm interve...

Descripción completa

Detalles Bibliográficos
Autores principales: Akasaka, Hiroshi, Sugimoto, Ken, Shintani, Ayumi, Taniuchi, Satsuki, Yamamoto, Koichi, Iwakura, Katsuomi, Okamura, Atsunori, Takiuchi, Shin, Fukuda, Masahiro, Kamide, Kei, Fujio, Yasushi, Nakatani, Satoshi, Ogihara, Toshio, Rakugi, Hiromi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles: Epidemiology, Clinical Practice and Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305927/
https://www.ncbi.nlm.nih.gov/pubmed/35212104
http://dx.doi.org/10.1111/ggi.14363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305927/
https://www.ncbi.nlm.nih.gov/pubmed/35212104
http://dx.doi.org/10.1111/ggi.14363

Ejemplares similares